Evidence map›Paper›PMID 40014308›Full record

ArticleSalud colectiva2025

[Approach to the use and complications of injectable liquid silicone in the trans and travesti population: experiences of healthcare professionals in Argentina].

Constanza Lupi, Daniela Paola Bruno, Diego Daniel Salusso, Estefanía Panizoni, Lara Weitz, Cecilia Valeriano, Inés Aristegui

Abstract readEnglish Abstract
In one paragraph

Article in Salud colectiva, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Constanza LupiSpecialist in Planning and Management of Social Policies. Coordinator, Programs Directorate, Fundación Huésped, Autonomous City of Buenos Aires, Argentina.ORCID 0009-0002-6719-9424
Daniela Paola BrunoPhD in Social Sciences. Researcher, Instituto de Investigaciones Gino Germani, Facultad de Ciencias Sociales, Universidad de Buenos Aires, Autonomous City of Buenos Aires, Argentina.ORCID 0000-0002-7071-4733
Diego Daniel SalussoMedical Specialist in Infectious Diseases. Clinical Researcher, Fundación Huésped. Adjunct Professor, Facultad de Medicina, Universidad de Buenos Aires. Autonomous City of Buenos Aires, Argentina.ORCID 0000-0002-6735-7173
Estefanía PanizoniPhysician specialized in Medical Clinic. Social Researcher, Implementation Research Division, Fundación Huésped, Autonomous City of Buenos Aires, Argentina.ORCID 0009-0009-9252-666X
Lara WeitzDiploma in Health Policies in the Territory. Programs Directorate, Fundación Huésped, Autonomous City of Buenos Aires, Argentina. lara.weitz@huesped.org.ar.ORCID 0009-0007-0395-0350
Cecilia ValerianoDiploma in Community Treatment. Program Director, Fundación Huésped, Autonomous City of Buenos Aires, Argentina.ORCID 0009-0009-7533-0868
Inés AristeguiPhD. in Psychology. Director, Implementation Research Division, Fundación Huésped, Autonomous City of Buenos Aires, Argentina.ORCID 0000-0002-1196-5620

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of injectable liquid silicone (ILS) in the travesti and trans population poses a public health challenge in Argentina and worldwide. Although ILS and other unauthorized polymers represent a significant risk for this population, there is no consensual and effective approach, nor has the issue been addressed through health policy. This study aimed to explore the experiences of healthcare professionals from various specialties and levels of care regarding the use, management, and treatment of ILS-related complications in trans and travesti individuals. Between August and December 2023, a qualitative, exploratory and descriptive study was carried out with 14 semi-structured interviews with health professionals from four Argentine provinces. According to their accounts, ILS users constitute a population facing multiple vulnerabilities, resorting to these practices due to the immediacy of results and the barriers to accessing safe gender-affirming procedures. Professionals agree on the lack of information and guidelines for addressing ILS-related complications, particularly in managing chronic pain. Furthermore, ILS use is identified as a public health issue requiring an intersectoral and interdisciplinary approach.

Indexed as

Attitude of Health PersonnelHealth PersonnelSiliconesTransgender PersonsAdultArgentinaFemaleHumansInjectionsMaleMiddle AgedQualitative ResearchSiliconesAfirmación de géneroFeminizationGender-Affirming CareSilicone OilsSiliconesTravesti-trans community

Identifiers

PMID40014308
PMCPMC11925851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.